Welcome to our dedicated page for Park Dental Partners SEC filings (Ticker: PARK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Park Dental Partners's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Park Dental Partners's regulatory disclosures and financial reporting.
Park Dental Partners, Inc. filed a current report to inform investors about its upcoming Annual Shareholder Meeting. The company issued a press release on January 29, 2026 announcing the meeting date, which is included as Exhibit 99.1.
The company also stated that shareholder nominations of directors must be received no later than ten days after the date of that press release. This deadline is important for any shareholders who wish to propose director candidates under the company’s governance procedures.
Kennedy Capital Management LLC has filed a Schedule 13G disclosing a significant ownership position in Park Dental Partners, Inc. common stock. As of 12/31/2025, the firm beneficially owned 235,632 shares, representing 5.8% of the outstanding common stock. Kennedy Capital reports sole power to vote and to dispose of all of these shares, with no shared voting or dispositive power. The firm certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Park Dental Partners.
Park Dental Partners, Inc. reported an amended insider transaction for its CEO and chairman, Peter Swenson. The correction states that on December 3, 2025 he purchased 3,169 shares of the company’s common stock at $13 per share, instead of the previously reported 3,846 shares. Following this purchase, he beneficially owned 238,381 common shares directly.
Park Dental Partners, Inc. director and Chief Financial Officer Christopher Bernander filed an initial insider ownership report showing beneficial ownership of 53,833 shares of common stock, all in the form of restricted stock. These restricted shares vest 25% upon completion of the company’s initial public offering and then 6.25% each quarter thereafter. The award is also subject to accelerated vesting in connection with a change in control under the company’s 2023 Restricted Stock Plan and the related award agreement. The restricted stock does not carry voting rights until the shares vest and Bernander becomes the record owner of those vested shares.